NeoGenomics Q4 revenue up 10% to $139M; net loss narrows to $23M; issues 2023 guidance with improved EBITDA

NEOGENOMICS INC

Q4 revenue $139M (+10% YoY); full year revenue $510M (+5% YoY).
Q4 net loss $23M vs $42M loss in Q4 2021; full year net loss $144M vs $8M loss in 2021 (2021 included $109M Inivata gain).
Q4 adjusted EBITDA -$1.2M vs -$10M in Q4 2021; full year adjusted EBITDA -$48M vs -$4M in 2021.
2023 guidance: revenue $545-555M (7-9% growth), adjusted EBITDA $(27)-$(22)M (44-54% improvement).
Cash and marketable securities $438M at quarter end.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NEOGENOMICS INC reported full year ended December 31, 2022 results: revenue $510 million, net income $144 million. Guidance initiated.

Period: full year ended December 31, 2022
Revenue: $510 million
Net income: $144 million
Guidance: initiated
Result: reported results

Exact text from the filing

Consolidated revenue for 2022 was $510 million, an increase of 5% over 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

NEOGENOMICS INC reported the fourth quarter of 2022 results: revenue $139 million, net income $23 million. Guidance initiated.

Period: the fourth quarter of 2022
Revenue: $139 million
Net income: $23 million
Guidance: initiated
Result: reported results

Exact text from the filing

Consolidated revenue for the fourth quarter of 2022 was $139 million, an increase of 10% over the same period in 2021.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-23-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.